patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
giredestrant
pre_registrationupdated 2mo agoby Genentech Inc🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
indications
indications
Breast Cancer
targets
Estrogen receptor
all catalysts(0)
nothing on the calendar yet
News(2)
- Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs<p>On a conference call, executives claimed that a closely watched breast cancer pill and portfolio of weight loss medicines could bank more than $9 billion annually.</p>biopharma_dive · 2mo ago
- Roche says its investigational breast cancer pill could outsell HerceptinRoche still has high sales hopes for its breast cancer pill giredestrant despite the drug’s failure in a first-line trial earlier this year. CEO Thomas Schinecker said Thursday that the drug coul…endpoints · 2mo ago
comments(0)
5-min edit window · permanent after that